Cardinal Sales General And Administrative To Revenue from 2010 to 2025

CAH Stock  USD 128.18  0.00  0.00%   
Cardinal Health's Sales General And Administrative To Revenue is increasing with slightly volatile movements from year to year. Sales General And Administrative To Revenue is estimated to finish at 0.04 this year. For the period between 2010 and 2025, Cardinal Health, Sales General And Administrative To Revenue quarterly trend regression had mean deviation of  0 and range of 0.0175. View All Fundamentals
 
Sales General And Administrative To Revenue  
First Reported
2010-12-31
Previous Quarter
0.0396
Current Value
0.0424
Quarterly Volatility
0.00434068
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardinal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardinal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 857.3 M, Interest Expense of 73.2 M or Selling General Administrative of 6 B, as well as many indicators such as Price To Sales Ratio of 0.25, Dividend Yield of 0.0038 or PTB Ratio of 2.08. Cardinal financial statements analysis is a perfect complement when working with Cardinal Health Valuation or Volatility modules.
  
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.

Latest Cardinal Health's Sales General And Administrative To Revenue Growth Pattern

Below is the plot of the Sales General And Administrative To Revenue of Cardinal Health over the last few years. It is Cardinal Health's Sales General And Administrative To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
Sales General And Administrative To Revenue10 Years Trend
Slightly volatile
   Sales General And Administrative To Revenue   
       Timeline  

Cardinal Sales General And Administrative To Revenue Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.03
Coefficient Of Variation12.90
Mean Deviation0
Median0.03
Standard Deviation0
Sample Variance0.000019
Range0.0175
R-Value0.62
Mean Square Error0.000012
R-Squared0.39
Significance0.01
Slope0.0006
Total Sum of Squares0.0003

Cardinal Sales General And Administrative To Revenue History

2025 0.0424
2024 0.0396
2018 0.0345
2017 0.0336
2016 0.029
2015 0.03
2014 0.0316

About Cardinal Health Financial Statements

Investors use fundamental indicators, such as Cardinal Health's Sales General And Administrative To Revenue, to determine how well the company is positioned to perform in the future. Although Cardinal Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 0.04  0.04 

Currently Active Assets on Macroaxis

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.1
Dividend Share
2.017
Earnings Share
5.37
Revenue Per Share
916.602
Quarterly Revenue Growth
(0.04)
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.